Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gefitinib + Pemetrexed/Cisplatin in Advanced NSCLC
NCT01192243Phase 2Unknown
- Sponsor
- Fudan University
- Start
- Dec 2009
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gefitinib in non-small cell lung cancer (NSCLC), sponsored by Fudan University. Status: unknown.
02
Drugs
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT01192243.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01192243.